News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Carl Ola Landgren: With Minimal Residual Disease (MRD) as an early endpoint for accelerated approval of new multiple myeloma drugs, patients access to new therapies will be much quicker
Photo taken from Carl Ola Landgren/Twitter
Apr 26, 2024, 14:15

Carl Ola Landgren: With Minimal Residual Disease (MRD) as an early endpoint for accelerated approval of new multiple myeloma drugs, patients access to new therapies will be much quicker

Carl Ola Landgren, Chief of the Myeloma Division and Translational Clinical Oncology Program at Sylvester Comprehensive Cancer Center, shared a post on X/Twitter:

“With Minimal Residual Disease (MRD) as an early endpoint for accelerated approval of new multiple myeloma drugs, patients’ access to new therapies will be much quicker.

Instead of waiting for 10-15 years, new drugs can be available in 3-5 years. Here is how it works.”

Source: Carl Ola Landgren/X

 

cancer Carl Ola Landgren MRD multiple myeloma Myeloma OncoDaily Oncology Sylvester Comprehensive Cancer Center Translational Clinical Oncology With Minimal Residual Disease
Special Coverage
Blog
May 31, 2025, 00:14
Prisca Githuka Calls for Stronger Tobacco Control Ahead of World No Tobacco Day 2025
Blog
May 30, 2025, 23:58
Oriol Mirallas: My Top 10 Drug Development Abstracts at ASCO25
Insight
May 30, 2025, 20:45
Neeraj Agarwal Congratulated Michael Ong and Soumyajit Roy on ASCO 2025 Abstract
Blog
May 30, 2025, 20:40
Giannis Mountzios: Charu Aggarwal is a Pioneer in Liquid Biopsies and Inspirational Leader
Blog
May 30, 2025, 20:35
Ishwaria Subbiah: Fresh From Celebrating Our Little Graduates, Now Off To ASCO 2025
Insight
May 30, 2025, 20:29
Hadi Mohamad Abu Rasheed: Air Pollution Is Not Only an Environmental Issue - It’s a Public Health Emergency
Insight
May 30, 2025, 20:23
Enrique Velazquez Villarreal on Joining Amplity Discussion on AI and Cancer at ASCO 2025
Blog
May 30, 2025, 20:19
Zineb Dahbi: Don't Miss the Next IGRT Masterclass in Casablanca
Blog
May 30, 2025, 20:15
Janet Fanaki Shares Insights on Navigating Glioblastoma Diagnosis in WeTrials' Caregiver Chronicles
Blog
May 30, 2025, 20:09
Commemorating World No Tobacco Day 2025: Walking Towards a Smoke Free Future - CARIG
Blog
May 30, 2025, 19:22
William’s Journey with NF1 Highlights the Urgent Need for Pediatric Cancer Research - St. Baldrick's Foundation
Blog
May 30, 2025, 19:12
Blood Cancer Awareness Day 2025: Building Diagnostic Capacity in Cameroon - World Child Cancer